Evidence map›Paper›PMID 37160600›Full record

ArticleBulletin of experimental biology and medicine2023

In Vivo DYSF Gene Viral Delivery Provides a Histoprotective Effect in Skeletal Muscle Tissue in Dysferlin-Deficient Mice.

I A Yakovlev, O N Chernova, M O Mavlikeev, I S Limaev, K A Blagodatskikh, A A Titova, A M Aimaletdinov, A A Shaimardanova, A A Rizvanov, S N Bardakov and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Bulletin of experimental biology and medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

I A YakovlevPJSC Human Stem Cells Institute, Moscow, Russia. ivan@ivan-ya.ru.
O N ChernovaI. I. Mechnikov North-West State Medical University, Ministry of Health of the Russian Federation, St. Petersburg, Russia.
M O MavlikeevI. I. Mechnikov North-West State Medical University, Ministry of Health of the Russian Federation, St. Petersburg, Russia.
I S LimaevI. I. Mechnikov North-West State Medical University, Ministry of Health of the Russian Federation, St. Petersburg, Russia.
K A BlagodatskikhLLC Genetico, Center for Genetics and Reproductive Medicine, Moscow, Russia.
A A TitovaKazan (Volga region) Federal University, Kazan, Republic of Tatarstan, Russia.
A M AimaletdinovKazan (Volga region) Federal University, Kazan, Republic of Tatarstan, Russia.
A A ShaimardanovaKazan (Volga region) Federal University, Kazan, Republic of Tatarstan, Russia.
A A RizvanovKazan (Volga region) Federal University, Kazan, Republic of Tatarstan, Russia.
S N BardakovS. M. Kirov Military Medical Academy, St. Petersburg, Russia.
A A IsaevPJSC Human Stem Cells Institute, Moscow, Russia.
R V DeevPJSC Human Stem Cells Institute, Moscow, Russia.
Kazan Federal University · RUHuman Stem Cells Institute PJSC (Russia) · RUResearch Centre for Medical Genetics · RUS. M. Kirov Military Medical Academy · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We studied the effects of a dual-vector DYSF gene delivery system based on adeno-associated virus serotype 9 capsids on pathological manifestations of dysferlinopathy in skeletal muscles of Bla/J mice lacking DYSF expression. The mice received intravenous injection of 3×10

Indexed as

Muscle, SkeletalMuscular Dystrophies, Limb-GirdleAnimalsDysferlinGene Transfer TechniquesMiceMice, Inbred C57BLMuscle Fibers, SkeletalDysferlinDysf protein, mouseadeno-associated virusdysferlinopathygene therapymuscular dystrophy

Identifiers

PMID37160600
OpenAlexW4376106230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.